Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia

Neuroscience

• Dementia Praecox 100%
• Recognition 90%
• Atypical Antipsychotic 80%
• Cognitive Disorders 60%
• Agonist 20%
• Gamma-Aminobutyric Acid 20%
• Tandospirone 20%
• Lurasidone 20%
• Methyldienolone 20%
• Dextro Aspartic Acid 20%
• Declarative Memory 20%
• Acetylcholine 10%
• Haloperidol 10%
• Dopamine 10%
• Receptor Antagonist 10%
• Serotonin 10%
• Serotonergic 10%
• Phencyclidine 10%
• Receptor Antagonists 10%
• Typical Antipsychotic 10%
• Dizocilpine 10%
• Ketamine 10%
• 4 Amino 2 oxabicyclo[3.1.0]hexane 4,6 Dicarboxylic Acid 10%
• Perphenazine 10%
• Interneuron 10%
• Cognitive Function 10%

INIS

• drugs 90%
• rodents 80%
• receptors 20%
• doses 20%
• effective doses 20%
• humans 10%
• patients 10%
• risks 10%
• administration 10%
• hypothesis 10%
• losses 10%
• primates 10%
• etiology 10%
• dopamine 10%
• serotonin 10%
• acetylcholine 10%
• restoration 10%